Rashmi Murthy, MD
Internal Medicine · Houston, TXNPI 1124273990
Payments from drug & device makers
Across 580 payments — averaging $11,518 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$3M
- Seagen Inc.$1.9M
- Daiichi Sankyo Inc.$1M
- Daiichi Sankyo Company LTD$603K
- Hoffmann-la Roche Limited$169K
- AstraZeneca$11K
- plus $21K from 6 others
Across 2 payments — averaging $1630.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$3K
- Seagen Inc.$60
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 144 | $3,001,232 |
| Seagen Inc. | 149 | $1,869,524 |
| Daiichi Sankyo Inc. | 236 | $1,006,649 |
| Daiichi Sankyo Company LTD | 13 | $603,110 |
| Hoffmann-la Roche Limited | 8 | $168,924 |
| AstraZeneca | 13 | $10,676 |
| Genentech USA, Inc. | 10 | $8,735 |
| Novartis | 2 | $4,531 |
| Sanofi | 1 | $3,270 |
| Genentech, Inc. | 1 | $2,824 |
| Janssen Research & Development, LLC | 2 | $1,100 |
| Puma Biotechnology, Inc. | 1 | $50 |
How this compares
$6,680,626 in reported general payments places this provider in the 95th percentile of 7,675 internal medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Houston
- Jan BurgerHouston$47.3M
- Nitin JainHouston$33.2M
- Aung NaingHouston$30.6M
- Preetesh JainHouston$19.5M
- Paolo StratiHouston$19.2M
- Nicholas ShortHouston$17.6M
- Isabella GlitzaHouston$14.8M
- Murtaza MussajiHouston$13.1M
- Hussein TawbiHouston$12.6M
- Hans LeeHouston$11.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.